|
Volumn 8, Issue 5, 1999, Pages 567-573
|
Synthetic inhibitors of coagulation factor Xa
|
Author keywords
Factor Xa; Thrombosis; Warfarin
|
Indexed keywords
(3' AMIDINO 3 BIPHENYLYL) 5 (4 PYRIDYLAMINO)PENTANOIC ACID;
2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID;
[N [4 [(1 ACETIMIDOYL 4 PIPERIDYL)OXY]PHENYL] N [(7 AMIDINO 2 NAPHTHYL)METHYL]SULFAMOYL]ACETIC ACID;
[N [4 [(1 ACETIMIDOYL 4 PIPERIDYL)OXY]PHENYL] N [(7 AMIDINO 2 NAPHTHYL)METHYL]SULFAMOYL]ACETIC ACID MONOMETHANE SULFATE;
ANTICOAGULANT AGENT;
BLOOD CLOTTING FACTOR 10A;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
BX 807834;
C 921 78;
FONDAPARINUX;
HEPARIN DERIVATIVE;
N [1 (2 AMINOIMINOMETHYL 4 THIENYLMETHYL) 2 OXO 3 PYRROLIDINYL] 7 METHOXY N METHYL 2 NAPHTHALENESULFONAMIDE;
N ACETYL 4 (AMINOIMINOMETHYL)PHENYLALANYL 2 CYCLOHEXYLGLYCYL 3 (1 METHYLPYRIDINIUM 3 YL) ALANYLLEUCYLPROLINAMIDE;
PYRAZOLE DERIVATIVE;
SA 862;
SF 034;
SN 429;
UNCLASSIFIED DRUG;
WARFARIN;
ANTICOAGULANT THERAPY;
CLINICAL TRIAL;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG HALF LIFE;
HUMAN;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
REVIEW;
THROMBOSIS;
|
EID: 0032949702
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.8.5.567 Document Type: Review |
Times cited : (11)
|
References (36)
|